Study finds Mark Cuban’s cost plus drug company could save taxpayers millions on Medicare generic oncology drugs
The U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the… read more.
